0001209191-15-045582.txt : 20150521
0001209191-15-045582.hdr.sgml : 20150521
20150521182858
ACCESSION NUMBER: 0001209191-15-045582
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150519
FILED AS OF DATE: 20150521
DATE AS OF CHANGE: 20150521
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ONCOGENEX PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000949858
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 954343413
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 19820 NORTH CREEK PARKWAY
STREET 2: SUITE 201
CITY: BOTHELL
STATE: WA
ZIP: 98011
BUSINESS PHONE: 425-686-1500
MAIL ADDRESS:
STREET 1: 19820 NORTH CREEK PARKWAY
STREET 2: SUITE 201
CITY: BOTHELL
STATE: WA
ZIP: 98011
FORMER COMPANY:
FORMER CONFORMED NAME: SONUS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19950825
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cormack Scott Daniel
CENTRAL INDEX KEY: 0001442675
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 033-80623
FILM NUMBER: 15884056
MAIL ADDRESS:
STREET 1: 400-1001 WEST BROADWAY
CITY: VANCOUVER
STATE: A1
ZIP: V6H 4B1
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-05-19
0
0000949858
ONCOGENEX PHARMACEUTICALS, INC.
OGXI
0001442675
Cormack Scott Daniel
400-1001 W. BROADWAY
VANCOUVER
A1
V6H 4B1
BRITISH COLUMBIA, CANADA
1
1
0
0
President and CEO
Common Stock
2015-05-19
4
M
0
15624
0.00
A
114681
D
Common Stock
2015-05-20
4
S
0
7543
1.88
D
107138
D
Restricted Stock Unit (RSU)
2015-05-19
4
M
0
4687
0.00
D
2016-01-31
Common Stock
4687
4687
D
Restricted Stock Unit (RSU)
2015-05-19
4
M
0
4687
0.00
D
2017-01-31
Common Stock
4687
9375
D
Restricted Stock Unit (RSU)
2015-05-19
4
M
0
6250
0.00
D
2018-04-13
Common Stock
6250
18750
D
Stock Option (right to buy)
1.86
2015-05-19
4
A
0
75000
0.00
A
2025-05-19
Common Stock
75000
75000
D
Restricted Stock Unit (RSU)
2015-05-19
4
A
0
37500
0.00
A
2019-06-18
Common
37500
37500
D
Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II.
Represents shares of common stock that have been sold by the issuer to satisfy the tax liability in connection with the settlement of RSUs.
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at settlement.
Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest on March 12, 2013 and then annually on the later of: (i) each anniversary of January 1, 2012; and (ii) the first day thereafter during which the issuer's trading window is open.
Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of January 1, 2013; and (ii) the first day thereafter during which the issuer's trading window is open.
Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of January 1, 2014; and (ii) the first day thereafter during which the issuer's trading window is open.
The options vest in monthly installments over 48 months commencing one month from January 1, 2015.
Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of January 1, 2015; and (ii) the first day thereafter during which the issuer's trading window is open.
Sandra Thomson as attorney-in-fact for Scott Cormack
2015-05-21